# Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)

> **NCT01371461** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 390 (actual)

## Conditions studied

- Mental Disorders

## Interventions

- **DRUG:** Paroxetine

## Key facts

- **NCT ID:** NCT01371461
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2004-07
- **Final completion:** 2004-10
- **Target enrollment:** 390 (ACTUAL)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01371461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01371461, "Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01371461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*